Applied Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Applied Therapeutics
APLT Stock  USD 0.52  0.03  5.45%   
Applied Therapeutics financial statements provide useful quarterly and yearly information to potential Applied Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Applied Therapeutics financial statements helps investors assess Applied Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Applied Therapeutics' valuation are summarized below:
Gross Profit
-52.6 M
Market Capitalization
63.6 M
Enterprise Value Revenue
62.3697
Revenue
-212 K
Earnings Share
(1.42)
There are currently one hundred twenty fundamental signals for Applied Therapeutics that can be evaluated and compared over time across rivals. All traders should validate Applied Therapeutics' prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 176.7 M in 2025. Enterprise Value is likely to drop to about 152.4 M in 2025

Applied Therapeutics Total Revenue

12.07 Million

Check Applied Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 1.7 M, Interest Income of 1.1 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 22.59, Dividend Yield of 0.0 or Days Sales Outstanding of 8.33. Applied financial statements analysis is a perfect complement when working with Applied Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Applied Therapeutics Correlation against competitors.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

Applied Therapeutics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets56.5 M63.1 M31.4 M
Slightly volatile
Other Current Liabilities82.2 M78.2 M18.5 M
Slightly volatile
Total Current Liabilities86 M81.9 M21.7 M
Slightly volatile
Accounts Payable1.9 M2 M2.4 M
Slightly volatile
Cash34.4 M57.4 M20.8 M
Slightly volatile
Cash And Short Term Investments50.1 M57.4 M28.1 M
Slightly volatile
Common Stock Shares Outstanding101.7 M96.9 M29 M
Slightly volatile
Liabilities And Stockholders Equity56.5 M63.1 M31.4 M
Slightly volatile
Capital Surpluse293.2 M279.2 M103.2 M
Slightly volatile
Other Current Assets5 M4.8 M2.6 M
Slightly volatile
Other Stockholder Equity545.1 M519.1 M158.4 M
Slightly volatile
Total Liabilities86.9 M82.8 M25.3 M
Slightly volatile
Total Current Assets55.4 M62.5 M30.8 M
Slightly volatile
Short and Long Term Debt Total1.1 M699.3 K1.7 M
Slightly volatile
Property Plant And Equipment Net382.2 K402.3 K1.8 M
Slightly volatile
Current Deferred Revenue570.3 K600.3 K5.3 M
Very volatile
Capital Lease Obligations399.3 K420.3 K1.6 M
Slightly volatile
Property Plant And Equipment Gross382.2 K402.3 K1.6 M
Slightly volatile
Net Receivables318 K256.5 K450.9 K
Slightly volatile
Non Current Liabilities Other681.3 K683.1 K1.1 M
Slightly volatile

Applied Therapeutics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income1.1 M1.6 M561.8 K
Slightly volatile
Selling General Administrative21.9 M23.7 M11.8 M
Slightly volatile
Other Operating Expenses66.1 M85.7 M37.7 M
Slightly volatile
Research Development44.2 M62 M25.8 M
Slightly volatile
Total Operating Expenses66.1 M85.7 M37.7 M
Slightly volatile
Reconciled Depreciation355.3 K407.1 K161.5 K
Slightly volatile
Selling And Marketing Expenses282.4 K317.7 K346.4 K
Slightly volatile

Applied Therapeutics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation6.7 M8.5 M3.6 M
Slightly volatile
Begin Period Cash Flow26.5 M19.2 M13.4 M
Slightly volatile
Other Cashflows From Financing Activities6.9 M10.7 M7.7 M
Very volatile
Depreciation261 K407.1 K155.6 K
Slightly volatile
Total Cash From Financing Activities63.3 M85.7 M37.3 M
Slightly volatile
End Period Cash Flow34.4 M57.4 M20.8 M
Slightly volatile
Change To Netincome6.8 M12.4 M4.7 M
Slightly volatile
Issuance Of Capital Stock69.8 M74.2 M43.4 M
Slightly volatile
Cash And Cash Equivalents Changes30.9 M34.8 M37.9 M
Slightly volatile
Cash Flows Other Operating1.2 M1.4 M1.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio22.5925.4227.7121
Slightly volatile
Days Sales Outstanding8.339.3710.2148
Slightly volatile
Stock Based Compensation To Revenue0.590.660.7226
Slightly volatile
EV To Sales18.6620.9922.8885
Slightly volatile
Payables Turnover0.210.230.0877
Slightly volatile
Sales General And Administrative To Revenue1.651.862.0252
Slightly volatile
Research And Ddevelopement To Revenue4.314.855.2925
Slightly volatile
Cash Per Share0.650.681.1395
Slightly volatile
Days Payables Outstanding2 K2.1 K88.4 K
Slightly volatile
Income Quality0.840.530.7445
Very volatile
Current Ratio0.830.882.8801
Slightly volatile
Receivables Turnover28.0531.5634.4059
Slightly volatile
Revenue Per Share0.0960.110.1167
Slightly volatile
Interest Debt Per Share0.01010.01060.1183
Slightly volatile
Debt To Assets0.02440.01630.0332
Slightly volatile
Days Of Payables Outstanding2 K2.1 K88.4 K
Slightly volatile
Ebt Per Ebit0.921.671.1031
Slightly volatile
Long Term Debt To Capitalization0.08740.08330.0548
Slightly volatile
Quick Ratio0.830.882.8833
Slightly volatile
Net Income Per E B T1.091.141.0103
Slightly volatile
Cash Ratio0.770.812.4684
Slightly volatile
Days Of Sales Outstanding8.339.3710.2148
Slightly volatile
Fixed Asset Turnover17.8920.1221.9369
Slightly volatile
Debt Ratio0.02440.01630.0332
Slightly volatile
Price Sales Ratio22.5925.4227.7121
Slightly volatile
Asset Turnover0.140.160.1782
Slightly volatile
Gross Profit Margin0.770.870.9466
Slightly volatile

Applied Therapeutics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap176.7 M254 M161.2 M
Slightly volatile
Enterprise Value152.4 M209.8 M142.3 M
Slightly volatile

Applied Fundamental Market Drivers

Cash And Short Term Investments49.9 M

Applied Upcoming Events

28th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Applied Therapeutics Financial Statements

Applied Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Applied Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Applied Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Applied Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue600.3 K570.3 K
Total Revenue11.5 M12.1 M
Cost Of Revenue405.9 K253.3 K
Stock Based Compensation To Revenue 0.66  0.59 
Sales General And Administrative To Revenue 1.86  1.65 
Research And Ddevelopement To Revenue 4.85  4.31 
Revenue Per Share 0.11  0.10 
Ebit Per Revenue(5.81)(6.10)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY